Seattle, United States
Amnis Corporation is a pioneering entity in the field of imaging flow cytometry. The company developed the ImageStream and FlowSight platforms, which uniquely combine high-resolution imaging capabilities with rapid cell analysis. These platforms enable the simultaneous capture of 12 high-resolution images per cell in fluid flow at impressive rates of up to 5,000 cells per second, a feat that significantly surpasses the fluorescence sensitivity of traditional microscopy or flow cytometry methods.
Founded in 1999 by David Basiji and William Ortyn, Amnis boasts more than 50 issued US and international patents protecting its innovative technology. The company was acquired in 2011 by EMD Millipore—now MilliporeSigma, part of Merck KGaA—for a noteworthy sum of $110 million. In a strategic business move, MilliporeSigma divested Amnis to Luminex Corporation in late 2018.
